Is Quality a Casualty in the Race to Publish?

WASHINGTON—Last spring’s newspaper stories that described how IBM researchers had boosted the critical current density of a superconductive thin-film crystal by a factor of 100 were also bringing news of the discovery to most scientists. Not until six weeks later were the details published in Physical Review Letters. Increasingly, scientists in fast-paced fields are announcing breakthroughs at meetings or press conferences. Long before results appear in scientific journals, they

Written byStephen Greene
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—Last spring’s newspaper stories that described how IBM researchers had boosted the critical current density of a superconductive thin-film crystal by a factor of 100 were also bringing news of the discovery to most scientists. Not until six weeks later were the details published in Physical Review Letters.

Increasingly, scientists in fast-paced fields are announcing breakthroughs at meetings or press conferences. Long before results appear in scientific journals, they circulate in the popular press, by word of mouth, as preprints or in various newsletters, databases and other sources set up to convey information quickly. (See THE SCIENTIST, July 13, 1987, p. 1.)

Some scientists worry about this departure from the established practice of announcing results only as they are published in a journal. “I find the trend a bit disturbing,” said M. Brian Maple, a physicist doing superconductivity research at the University of California at San Diego. When details of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies